[1] Lewis EJ, Hunsicker LG, Clapke WR, et al.Renoprotective effect of angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes[J].N Engl J Med, 2001;345:851-60
[2] Parving HH, Lehnert H, Brochner-mortensen J, et al.The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes[J].N Engl JMed, 2001;345:861-9
[3] Mezzano SA, Ruiz-Ortega M, Egido J.Angiotensin Ⅱ and renal fibrosis[J].Hyperteion, 2001;38:635-8
[4] Wolf G, Haberstroh U, Neilson EG.Angiotensin Ⅱ stimulates the proliferation and biosynthesis of type ? collagen in cultured murine mesangialcells[J].Am J Pathol, 1992;140:95-107
[5] Zatz R, Dunn BR, Meyer TW, et al.Prevention of diabet glomerulopathy by pharmacological amelioration of glomerular capillary hypertention[J].J Clin Invest, 1986;77:1925-30
[6] Abbate M, Zoja C, Corna D, et al.In progressive nephropathies, overload of tubular cells with filtered proteins translates glomerular permeability dysfunction into cellular signals of interstitial inflammation[J].J Am Soc Nephrol, 1998;9:1213-24
[7] O' donnell MP, Crary GS, Oda H, et al.Irbesartan lowers blood pressor and ameliorates renal injury in experimental noninsulin-dependent diabetes mellitus[J].Kindey Int, 1997;52(63 Supple 1):S218-S20
[8] Lewis EJ, Hunsicker LG, Bain RP, et al.The effect of angiotensin-coverting enzyme inhibition on diabetic nephropathy[J].N Engl J Med, 1993;329:1456-62
[9] Burnier M, Brunner HR.Angiotensin receptor antagonists[J].Lancet, 2000, 355:637-47
[10] 刘必成, 罗冬冬, 孙子林, 等.结缔组织生长因子在糖尿病大鼠肾脏中的表达及意义探讨[J].东南大学学报(医学版), 2002;1:36-9
[11] 罗冬冬, 刘必成, 张东升, 等.Irbesartan 对糖尿病大鼠毛细血管基底膜增厚的影响[J].东南大学学报(医学版),2002;1:89-92
[12] 罗冬冬, 刘必成, 王兆明, 等.伊贝沙坦对糖尿病大鼠结缔组织生长因子表达的影响[J].中国药科大学学报,2002;38:327-30 |
